The global bone allografts market size is anticipated to reach USD 3.53 billion in 2030 and is projected to grow at a CAGR of 9.4% from 2025 to 2030. The rising prevalence of dental problems, ongoing product commercialization, market accessibility & product affordability, rising elderly population, and increasing public awareness regarding preventative care are the major factors driving the demand for dental bone allografts. For instance, about 530 million children experience caries of their primary teeth, according to the World Health Organization (2020), which further estimates that nearly 3.5 billion people are affected by oral disorders. Furthermore, the growing demand for minimally-invasive procedures will also support market growth.
As Minimally Invasive Spine Surgery (MISS) does not require a big incision, it reduces the risk of major injury to the muscles surrounding the spine and allows the surgeon to see only the area of the spine where the problem arises. Due to these approaches, such as using fewer devices, the surgical field (also known as exposure) is smaller, resulting in less pain and a speedier recovery. These factors are expected to drive the overall industry. The industry had a decline in 2020 as a result of the COVID-19 pandemic. All elective surgeries, including spine surgery, were postponed, and the hospitals were transformed into recognized COVID-19 treatment facilities. Such elements consequently hampered the industry expansion.
The expansion of treatment access in many developing countries is likely to increase the demand for healthcare-related products, notably those connected to spinal surgery. The market would expand as a result of the rising demand for these goods, as major developing regions’ economies become more prosperous. Furthermore, due to the temporary shutdown of dental clinics and the fact that all healthcare providers were occupied with COVID-19, dental procedure volumes were substantially decreased. Access was limited to only the most basic care. For instance, the American Dental Association (ADA) advised delaying elective dental surgeries until April 6, 2020, and dental offices should only offer emergency dental care. These factors severely impacted the supply chains of dental bone graft substitute producers.
Thus, these data points suggest that during the COVID-19 pandemic, the demand for dental bone graft alternatives decreased. In dentistry, bone allografts are frequently used. A skilled clinician who can handle and position the allografts in the proper position is required for the preparation and processing for safe use and successful transplant material. The materials’ antigenicity and danger of disease transfer from donor to the recipient are the main issues. Other bone-related operations, from small flaws to significant bone loss following tumor removal, also use bone allografts. Furthermore, the increasing medical and dental tourism sector, burden of dental illnesses, and technical developments in the field of dentistry are also among the key factors contributing to the industry growth.
This product will be delivered within 1-3 business days.
As Minimally Invasive Spine Surgery (MISS) does not require a big incision, it reduces the risk of major injury to the muscles surrounding the spine and allows the surgeon to see only the area of the spine where the problem arises. Due to these approaches, such as using fewer devices, the surgical field (also known as exposure) is smaller, resulting in less pain and a speedier recovery. These factors are expected to drive the overall industry. The industry had a decline in 2020 as a result of the COVID-19 pandemic. All elective surgeries, including spine surgery, were postponed, and the hospitals were transformed into recognized COVID-19 treatment facilities. Such elements consequently hampered the industry expansion.
The expansion of treatment access in many developing countries is likely to increase the demand for healthcare-related products, notably those connected to spinal surgery. The market would expand as a result of the rising demand for these goods, as major developing regions’ economies become more prosperous. Furthermore, due to the temporary shutdown of dental clinics and the fact that all healthcare providers were occupied with COVID-19, dental procedure volumes were substantially decreased. Access was limited to only the most basic care. For instance, the American Dental Association (ADA) advised delaying elective dental surgeries until April 6, 2020, and dental offices should only offer emergency dental care. These factors severely impacted the supply chains of dental bone graft substitute producers.
Thus, these data points suggest that during the COVID-19 pandemic, the demand for dental bone graft alternatives decreased. In dentistry, bone allografts are frequently used. A skilled clinician who can handle and position the allografts in the proper position is required for the preparation and processing for safe use and successful transplant material. The materials’ antigenicity and danger of disease transfer from donor to the recipient are the main issues. Other bone-related operations, from small flaws to significant bone loss following tumor removal, also use bone allografts. Furthermore, the increasing medical and dental tourism sector, burden of dental illnesses, and technical developments in the field of dentistry are also among the key factors contributing to the industry growth.
Bone Allografts Market Report Highlights
- An increasing number of sports & trauma injury cases and orthopedic surgeries performed are factors expected to boost the industry growth
- The demineralized bone matrices type segment dominated the industry in 2024 owing to a high number of spinal fusion and dental surgeries performed
- The dental application segment held the largest share of the overall revenue in 2024 and is also expected to register the second-highest CAGR during the forecast period
- To replace missing teeth, bone grafting is done first. Bone grafts are additionally utilized in dentistry as fillers and scaffolds to enhance bone growth & accelerate wound healing, which is expected to propel the segment growth
- The hospitals end-use segment held the largest market share in 2024 due to the availability of technologically sophisticated implants for treating and diagnosing spine problems
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
- Competitive Landscape: Explore the market presence of key players worldwide
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
The leading players in the Bone Allografts market include:
- Zimmer Biomet
- Medtronic
- Stryker
- Smith+Nephew
- Lynch Biologics, LLC.
- Biomatlante
- Johnson & Johnson Services, Inc.
- Royal Biologics
- Baxter
- Xtant Medical
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Bone Allografts Market Variables, Trends & Scope
Chapter 4. Bone Allografts Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
Chapter 5. Bone Allografts Market Segment Analysis, By Application, 2018 - 2030 (USD Million)
Chapter 6. Bone Allografts Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
Chapter 7. Bone Allografts Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
List of Tables
List of figures
Companies Mentioned
- Zimmer Biomet
- Medtronic
- Stryker
- Smith+Nephew
- Lynch Biologics, LLC.
- Biomatlante
- Johnson & Johnson Services, Inc.
- Royal Biologics
- Baxter
- Xtant Medical
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 2.07 Billion |
| Forecasted Market Value ( USD | $ 3.53 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
